Other
Abdominoplasty
0
Pipeline Programs↗
0
Active Trials↗
3
Companies Involved↗
Abdominoplasty is an early-stage landscape with 0 programs across 3 companies. The most active players are Kythera Biopharmaceuticals, Tris Pharma, Inc., iX Biopharma Ltd..
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
15
clinical trials
Completed10 · 67%
Unknown status3 · 20%
Terminated2 · 13%
Clinical Trials
Trial Activity
15 trials
Study in Subjects Undergoing Complete Abdominoplasty
Completed·—·Phase 2·NCT03789318·54 enrolled
Transversus Abdominis Plane Blocks With Abdominoplasty
Unknown status·—·Phase 4·NCT01278264·60 enrolled
The Effect of Intravenous Nalbuphine on PONV With Intrathecal Morphine in Abdominoplasty.
Unknown status·—·N/A·NCT03786562·80 enrolled
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)